Smith+Nephew在FDA批准的新AETOS无丁植入为外科医生提供了新的肩膀替换选择。 Smith+Nephew's new FDA-approved AETOS Stemless implant offers surgeons a new option for shoulder replacements.

Smith+Nephew 已获得 FDA 的批准，用于一种新的无柄肩关节植入物 AETOS 无柄，旨在高效、稳定地进行解剖性肩关节置换术。 Smith+Nephew has received FDA approval for a new stemless shoulder implant, AETOS Stemless, designed for efficient and stable anatomic shoulder replacements. 新植入物包括一些特征,如十字架鳍和多孔涂层,以加强生物固定,使外科医生在AETOS肩膀系统内有更多选择。 The new implant includes features like a cruciate fin and porous coating to enhance biological fixation, offering surgeons more options within the AETOS Shoulder System. 这一发展满足了对肩膀替换日益增长的需求,而肩膀替换是矫形科领域迅速增长的一个领域。 This development meets the rising demand for shoulder replacements, a rapidly growing field in orthopedics.